BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 3933827)

  • 21. T lymphocyte characteristics in bone marrow-transplanted patients. II. Analysis with monoclonal antibodies.
    de Bruin HG; Astaldi A; Leupers T; van de Griend RJ; Dooren LJ; Schellekens PT; Tanke HJ; Roos M; Vossen JM
    J Immunol; 1981 Jul; 127(1):244-51. PubMed ID: 6787124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal T-cell colony formation in agar culture: an attractive assay to test the T-cell depletion from bone marrow.
    Farcet JP; Beaujean F; Cordonnier C; Pico J; Gourdin MF; Divine M; Bracq C; Bouguet J; Laurent G; Bernard A
    Exp Hematol; 1986 Dec; 14(11):1011-4. PubMed ID: 3536543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
    Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
    Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis.
    Small TN; Avigan D; Dupont B; Smith K; Black P; Heller G; Polyak T; O'Reilly RJ
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):65-75. PubMed ID: 9267666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
    Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
    Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased hematopoietic accessory cell function following bone marrow transplantation.
    Emerson SG; Sieff CA; Gross RG; Rozans MK; Miller RA; Rappeport JM; Nathan DG
    Exp Hematol; 1987 Nov; 15(10):1013-21. PubMed ID: 2959495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Elimination of leukemic CD34+ progenitor cells by using cytotoxic T lymphocytes specifically targeting WT1-derived peptide: an experimental study in vitro].
    Gu WY; Chen ZX; Qiu GQ; Hu SY; Jia L; Wu W; He J; Cen JN; He B
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3401-6. PubMed ID: 19159569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
    Ramakrishnan S; Uckun FM; Houston LL
    J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemic cell colony formation in soft agar by bone marrow cells and peripheral blood cells from untreated acute leukemia patients.
    Dicke KA; Tindle SE; Davis FM; Jagannath S; Tucker S; Lilien M; van Leeuwen P; Verma DS; Vellekoop L
    Exp Hematol; 1983 Apr; 11(4):341-50. PubMed ID: 6341080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of lymphocyte subsets after autologous bone marrow transplantation with marrow treated by ASTA Z 7557 in acute leukemia: incidence of the in vitro treatment.
    Le Blanc G; Douay L; Laporte JP; Dominh A; Deloux J; Najman A; Duhamel G; Gorin NC
    Exp Hematol; 1986 Jun; 14(5):366-71. PubMed ID: 3519264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cellular composition of human lymph nodes after allogenic bone marrow transplantation: an immunohistological study.
    Dilly SA; Sloane JP; Psalti IS
    J Pathol; 1986 Nov; 150(3):213-21. PubMed ID: 3543275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological reconstitution after allogeneic and autologous bone marrow transplantation.
    Harada M; Ueda M; Nakao S; Kondo K; Odaka K; Shiobara S; Matsue K; Mori T; Hattori K
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):245-52. PubMed ID: 2939601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
    Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G
    Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow T cell colony-forming cells: studies of their origin and use in monitoring T cell-depleted bone marrow grafts.
    Knott LJ; Levinsky RJ; Newland AC; Jones HM; Linch DC
    Clin Exp Immunol; 1985 Dec; 62(3):561-9. PubMed ID: 3910318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.